Markus Blanke archives

ISSX / EACPT, Geneva, June 7-10, 2020

On behalf of Meeting President, Jules Desmeules, and the entire Meeting Organizing Committee, it is our great pleasure to invite you to the 15th European ISSX (International Society for the Study of Xenobiotics) and EACPT (European Association for Clinical Pharmacology and Therapeutics) joint meeting held in beautiful Geneva, Switzerland.

This joint meeting – under the overarching theme “Precision Medicine from Bench to Bedside”- will bring together researchers from both experimental and clinical disciplines engaged in drug research, drug development, drug use, and clinical practice.…

14th Congress of the European Association for Clinical Pharmacology and Therapeutics

At the 14th EACPT congress, held in Stockholm from June 29th-July 2nd, the organization celebrated its 25th anniversary, attracting 500 participants from all 5 continents – from Australia to China, Japan and South Korea to the USA. 304 abstracts were presented as 66 short oral communications and 230 poster presentations by delegates from the European Region and around the world.…

2019 EACPT Prize for Lifetime Achievement in Clinical Pharmacology

Four outstanding candidates have been shortlisted for the prestigious 2019 EACPT Lifetime Achievement Award: Professor Kim Brosen, Denmark; Professor Adam Cohen, The Netherlands; Professor Stéphane Laurent, France; Professor Urs Meyer, Switzerland.

The European Association of Clinical Pharmacology & Therapeutics (EACPT) will present its 2019 Lifetime Achievement Award for work undertaken in Clinical Pharmacology at its Congress in Stockholm at the end of June.…

Magnus Ingelman-Sundberg is awarded the 2018 BCPT Nordic Prize in Basic and Clinical Pharmacology and Toxicology

The Nordic Association for the publication of “Basic & Clinical Pharmacology & Toxicology” has awarded the BCPT Nordic Prize in Basic and Clinical Pharmacology and Toxicology for 2018 to Professor Magnus Ingelman-Sundberg, Karolinska Institute (KI), Stockholm, Sweden

Magnus Ingelman-Sundberg has made a fundamental contribution to personalized medicine and individualized drug treatment. A significant part of this work has been produced in collaboration with clinical pharmacology, both in Sweden and globally.…

1 2 3 7
Skip to toolbar